National and Kapodistrian University of Athens
Μοριακή μελέτη της οξείας προμυελοκυτταρικής λευχαιμίας
Abstract
dc:descriptionAcute promyelocytic leukemia (APL) is one of acute myeloid leukemia (AML) subtypes. Since the late 1970s it has been appreciated that APL is correlated with the reciprocal translocation, t(15;17)(q22;q21), present in the majority of cases. The translocation disrupts the PML gene on chromosome 15 and the retinoic acid receptor-α (RARA) gene on chromosome 17. A variety of PML-RARA transcripts [bcr1 or Long (L), bcr3 or Short (S), bcr2 or Variable (V)] are produced due to different PML gene breakpoints and alternative splicing in chromosome 15. The FLT3 gene aberrations, including internal tandem duplications (ITDs) and D835 (tyrosine kinase domain, TKD) mutations occur in 30%-50% in APL. In APLs driven by the t(15,17) translocations, PML-RARA is most often the only driving genetic alteration; epigenetic changes seem limited. According to de The and his coauthors APL represents a monogenic cancer primarily, if not exclusively, driven by PML-RARA. The PML-RARA fusion gene can be detected by reverse transcription– polymerase chain reaction (RT-PCR) amplification, a very sensitive method with the ability to identify the different fusion transcripts. 548 BM and/or PB samples from 47 patients, suffering from APL, at presentation, after every cycle of chemotherapy and every 3 to 6 months till 5 years post diagnosis were studied.The molecular study included the detection and quantification of the PML-RARA hybrid gene and the detection of FLT3 gene mutations (TKD and ITD). In the beginning of this study and in order to select the best assay for MRD detection, a comparison of qualitative RT-nested PCR, already established in the laboratory, to the quantitative Real-time PCR for the detection of PML-RARA was performed. The result of the comparison led to the replacement of the conventional "nested" RT-PCR by RQ-PCR, because of the increased sensitivity and the ability of having immediate assessment of sample suitability. In order to find a way to shorten the time needed for the assessment of a sample at diagnosis, and after the observation that each of the hybrid gene transcript was detected with different sensitivity using the three different RQ-PCR assays standardized within the EAC program, a comparison of the conventional PCR and the three protocols of RQ-PCR was performed. The conclusions from this comparison led to the selection and the establishment of RQ-PCR as the most suitable method for rapid APL diagnosis. Two PCR assays followed by fragment analysis in a sequencer were established for the detection of FLT3 gene mutations (TKD and ITD). As refered in the literature, high prognostic value for predicting relapse has the detection of PML-RARA at the end of consolidation therapy, while MRD detection at the end of induction therapy has no value. Most studies have failed to confirm the prognostic significance of FLT3 gene mutations.As part of the efforts to define potential prognostic factors that may allow early distinction of patients at high risk to relapse, transcript levels at diagnosis were correlated to the patients’ outcome, without apparent significant correlation at least until now. It should be noted that no conclusions could be drawn due to the limited number of patients in this study. Nevertheless the application of quantitative PCR allowed the rapid and accurate diagnosis of APL, as well as the safe monitoring of MRD with great sensitivity. As the results of this study have shown, the close molecular monitoring of APL MRD using RQ-PCR can help predicting and subsequently preventing hematologic relapse by early intervention.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Garofalaki, Maria
- Γαροφαλάκη, Μαρία
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44831